공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 백혈구 성분채집술 시장 : 유형별(백혈구 성분채집술 디바이스, 백혈구 성분채집술 일회용), 용도별(연구 용도, 치료 용도), 최종사용자별 예측(-2025년) - COVID-19의 누적 영향

Leukapheresis Market Research Report by Type, by Application, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 1005042
페이지 정보 영문 187 Pages
가격
US $ 3,949 ₩ 4,523,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,669,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,105,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,396,000 PDF (Enterprise License) + Excel


세계의 백혈구 성분채집술 시장 : 유형별(백혈구 성분채집술 디바이스, 백혈구 성분채집술 일회용), 용도별(연구 용도, 치료 용도), 최종사용자별 예측(-2025년) - COVID-19의 누적 영향 Leukapheresis Market Research Report by Type, by Application, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 187 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 백혈구 성분채집술 시장 규모는 2020년 4,294만 달러에서 2025년 말까지 6,512만 달러로 확대될 것으로 예측됩니다.

COVID-19는 거의 모든 업계에 영향을 미친 전례 없는 세계적인 공중위생상 긴급사태이기 때문에 예측기간 중 업계의 성장에 장기적인 영향을 미칠 것으로 예측됩니다. 우리가 진행중인 조사는 조사 프레임워크를 넓히고, 기초가 되는 COVID-19의 문제와 향후 잠재적 방향을 확실하게 포함시키고 있습니다. 조사는 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재설정, 현재 시장 역학 및 정부의 중요한 개입을 고려한 COVID-19에 관한 인사이트를 제공합니다. 업데이트된 조사는 시장에 대한 COVID-19의 영향을 고려하여 인사이트, 분석, 추정 및 예측을 제공합니다.

세계의 백혈구 성분채집술(Leukapheresis) 시장에 대해 조사했으며, 시장 기회와 과제, 성장 촉진요인 및 억제요인, COVID-19의 누적 영향, 종류·용도·최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 기간
  • 통화와 가격
  • 언어
  • 제한 사항
  • 이해관계자

제2장 조사 방법

  • 조사 과정
    • 정의 : 조사 목적
    • 결정 : 조사 설계
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 분석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 업데이트
  • 조사 시행
    • 개시 : 조사 과정
    • 계획 : 조사 계획 작성
    • 시행 : 조사 시행
    • 검증 : 발견 및 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 개요

  • 시장 전망
  • 용도별 시장 전망
  • 최종사용자별 시장 전망
  • 유형별 시장 전망
  • 지역별 시장 전망
  • 경쟁사 전망

제4장 시장 개요

  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porter의 산업 분석

제6장 유형별 시장

  • 백혈구 성분채집술 기기
    • 원심 장치
    • 멤브레인 분리기
  • 백혈구 성분채집술 일회용퓸

제7장 용도별 시장

  • 연구 용도
  • 치료 용도

제8장 최종사용자별 시장

  • 학술기관/연구기관
  • 혈액 성분 프로바이더/혈액 센터
  • 위탁연구기관
  • 병원/수혈센터
  • 제약 기업/바이오테크놀러지 기업

제9장 아메리카 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제10장 아시아태평양 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제11장 유럽, 중동 및 아프리카 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

제12장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사의 SWOT 분석
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 계약/협업/제휴
    • 신제품 발매 및 개선
    • 투자 및 펀딩
    • 수상/인지/사업 확장

제13장 기업 개요

  • Allcells, LLC
  • Asahi Kasei Corporation
  • Beijing Zksk Technology Co. Ltd.
  • Bioivt
  • Caltag Medsystems Limited
  • Charles River Laboratories International, Inc.
  • Discovery Life Sciences
  • Fresenius Se & Co. Kgaa
  • Guangzhou Daji Medical Science and Technology Co. Ltd.
  • Haemonetics Corporation
  • Intelligent Tissue Group
  • Lonza Group Ag
  • Macopharma Sa
  • Medica Spa.
  • Miltenyi Biotec
  • Precision for Medicine, Inc.
  • Puriblood Medical Co. Ltd.
  • Stemexpress, LLC
  • Terumo BCT
  • Zenbio, Inc.

제14장 부록

  • 디스커션 가이드
  • 라이선스 및 가격
LSH 21.05.27

LIST OF FIGURES

  • FIGURE 1. GLOBAL LEUKAPHERESIS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL LEUKAPHERESIS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL LEUKAPHERESIS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2026
  • FIGURE 11. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 20. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 22. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2026
  • FIGURE 29. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. AMERICAS LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 40. AMERICAS LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 42. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. BRAZIL LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. CANADA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. MEXICO LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. CALIFORNIA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. FLORIDA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. ILLINOIS LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. NEW YORK LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. OHIO LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. PENNSYLVANIA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. TEXAS LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 55. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 57. CHINA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. INDIA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. INDONESIA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. JAPAN LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. THAILAND LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 66. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 68. FRANCE LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. GERMANY LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. ITALY LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. QATAR LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. RUSSIA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. SPAIN LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. GLOBAL LEUKAPHERESIS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 80. GLOBAL LEUKAPHERESIS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 81. GLOBAL LEUKAPHERESIS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL LEUKAPHERESIS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL LEUKAPHERESIS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. BRAZIL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CANADA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MEXICO LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CALIFORNIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CALIFORNIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. FLORIDA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. FLORIDA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ILLINOIS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ILLINOIS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. NEW YORK LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. NEW YORK LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. OHIO LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. OHIO LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PENNSYLVANIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PENNSYLVANIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. TEXAS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. TEXAS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. CHINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CHINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDONESIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDONESIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. JAPAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. JAPAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. THAILAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. THAILAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. FRANCE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. FRANCE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. GERMANY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. GERMANY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ITALY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. ITALY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. QATAR LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. QATAR LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. RUSSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. RUSSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SPAIN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SPAIN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. GLOBAL LEUKAPHERESIS MARKET: SCORES
  • TABLE 124. GLOBAL LEUKAPHERESIS MARKET: BUSINESS STRATEGY
  • TABLE 125. GLOBAL LEUKAPHERESIS MARKET: PRODUCT SATISFACTION
  • TABLE 126. GLOBAL LEUKAPHERESIS MARKET: RANKING
  • TABLE 127. GLOBAL LEUKAPHERESIS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 128. GLOBAL LEUKAPHERESIS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 129. GLOBAL LEUKAPHERESIS MARKET: MERGER & ACQUISITION
  • TABLE 130. GLOBAL LEUKAPHERESIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 131. GLOBAL LEUKAPHERESIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 132. GLOBAL LEUKAPHERESIS MARKET: INVESTMENT & FUNDING
  • TABLE 133. GLOBAL LEUKAPHERESIS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 134. GLOBAL LEUKAPHERESIS MARKET: LICENSE & PRICING
  • TABLE 135. GLOBAL LEUKAPHERESIS MARKET: CONTACT DETAILS

The Global Leukapheresis Market size was estimated at USD 42.93 Million in 2020 and expected to reach USD 46.88 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.52% to reach USD 74.11 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Leukapheresis to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Leukapheresis Market was studied across Leukapheresis Devices and Leukapheresis Disposables. The Leukapheresis Devices is further studied across Centrifugal Devices and Membrane Separators.

Based on Application, the Leukapheresis Market was studied across Research Applications and Therapeutic Applications.

Based on End-user, the Leukapheresis Market was studied across Academic & Research Institutes, Blood Component Providers & Blood Centers, Contract Research Organizations, Hospitals & Transfusion Centers, and Pharmaceutical & Biotechnology Companies.

Based on Geography, the Leukapheresis Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Leukapheresis Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Leukapheresis Market, including Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Leukapheresis Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Leukapheresis Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Leukapheresis Market?
  • 4. What is the competitive strategic window for opportunities in the Global Leukapheresis Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Leukapheresis Market?
  • 6. What is the market share of the leading vendors in the Global Leukapheresis Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Leukapheresis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. End-user Outlook
  • 3.5. Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing application in cancer therapy
      • 5.1.1.2. Demand for leukapheresis in clinical research
      • 5.1.1.3. Growth in initiatives for blood donations
    • 5.1.2. Restraints
      • 5.1.2.1. Possible risk of hypocalcemia and anemia or thrombocytopenia
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus and investment in R&D activities
      • 5.1.3.2. Leukapheresis for CAR or Adoptive Cell Therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Potential issues related to leukapheresis including discomfort, redness, and bruising
      • 5.1.4.2. Time consuming process of leukapheresis
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Leukapheresis Market, by Type

  • 6.1. Introduction
  • 6.2. Leukapheresis Devices
    • 6.2.1. Centrifugal Devices
    • 6.2.2. Membrane Separators
  • 6.3. Leukapheresis Disposables

7. Leukapheresis Market, by Application

  • 7.1. Introduction
  • 7.2. Research Applications
  • 7.3. Therapeutic Applications

8. Leukapheresis Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Blood Component Providers & Blood Centers
  • 8.4. Contract Research Organizations
  • 8.5. Hospitals & Transfusion Centers
  • 8.6. Pharmaceutical & Biotechnology Companies

9. Americas Leukapheresis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Leukapheresis Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Leukapheresis Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Allcells, LLC
  • 13.2. Asahi Kasei Corporation
  • 13.3. Beijing Zksk Technology Co. Ltd.
  • 13.4. Bioivt
  • 13.5. Caltag Medsystems Limited
  • 13.6. Charles River Laboratories International, Inc.
  • 13.7. Discovery Life Sciences
  • 13.8. Fresenius Se & Co. Kgaa
  • 13.9. Guangzhou Daji Medical Science and Technology Co. Ltd.
  • 13.10. Haemonetics Corporation
  • 13.11. Intelligent Tissue Group
  • 13.12. Lonza Group Ag
  • 13.13. Macopharma Sa
  • 13.14. Medica Spa.
  • 13.15. Miltenyi Biotec
  • 13.16. Precision for Medicine, Inc.
  • 13.17. Puriblood Medical Co. Ltd.
  • 13.18. Stemexpress, LLC
  • 13.19. Terumo BCT
  • 13.20. Zenbio, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details
Back to Top
전화 문의
F A Q